Shilpa Medicare, 530549, SHILPAMED Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,069.08
17.65
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,414.40
0.29%
2.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.08
4.85
4.80

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.76
6.04
7.24

PAT CAGR (%)

10 Years
5 Years
3 Years

12.23
7.34
11.65

P:E (Median)

8 Years
5 Years
3 Years

26.92
28.33
24.31

P:BV (Average)

8 Years
5 Years
3 Years

4.06
3.84
2.58

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.17
20.97
16.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 171.30 216.93 -21.03% 262.68 236.53 11.06% 216.64 154.56 40.17% 197.93 171.02 15.74%
Expenses 140.61 139.60 0.72% 181.30 161.22 12.46% 139.05 111.59 24.61% 148.66 128.69 15.52%
EBITDA 30.69 77.33 -60.31% 81.38 75.31 8.06% 77.59 42.98 80.53% 49.28 42.33 16.42%
EBIDTM 17.92% 35.65% 30.98% 31.84% 35.81% 27.80% 24.90% 24.75%
Other Income 8.61 2.43 254.32% 7.52 2.43 209.47% 2.64 3.43 -23.03% 2.97 3.49 -14.90%
Interest 3.95 1.09 262.39% 3.34 0.63 430.16% 3.54 1.32 168.18% 1.29 1.01 27.72%
Depreciation 10.48 8.62 21.58% 9.84 8.61 14.29% 9.91 8.57 15.64% 9.16 8.45 8.40%
PBT 24.87 70.04 -64.49% 75.72 68.50 10.54% 119.72 36.52 227.82% 37.26 28.38 31.29%
Tax 7.99 12.78 -37.48% 20.95 12.94 61.90% 33.58 7.28 361.26% 11.89 8.75 35.89%
PAT 16.88 57.27 -70.53% 54.78 55.56 -1.40% 86.14 29.24 194.60% 25.36 19.63 29.19%
PATM 9.85% 26.40% 20.85% 23.49% 39.76% 18.92% 12.81% 11.48%
EPS 2.07 7.03 -70.55% 6.72 6.82 -1.47% 10.57 3.59 194.43% 3.11 2.41 29.05%

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 191.25 236.85 -19.25% 278.94 289.92 -3.79% 222.87 160.99 38.44% 219.99 199.52 10.26%
Expenses 170.28 163.11 4.40% 210.25 221.91 -5.25% 157.11 132.19 18.85% 174.40 162.11 7.58%
EBITDA 20.97 73.74 -71.56% 68.68 68.00 1.00% 65.75 28.80 128.30% 45.60 37.40 21.93%
EBIDTM 10.96% 31.13% 24.62% 23.46% 29.50% 17.89% 20.73% 18.75%
Other Income 8.61 3.25 164.92% 9.20 5.82 58.08% 5.48 1.98 176.77% 8.91 3.09 188.35%
Interest 4.80 1.27 277.95% 3.95 0.82 381.71% 4.00 1.46 173.97% 1.01 1.41 -28.37%
Depreciation 13.72 10.97 25.07% 12.70 10.66 19.14% 12.33 10.66 15.67% 11.55 10.54 9.58%
PBT 11.05 64.76 -82.94% 61.23 62.34 -1.78% 115.74 18.66 520.26% 41.57 28.09 47.99%
Tax 2.92 10.53 -72.27% 15.99 11.18 43.02% 29.14 4.05 619.51% 7.55 5.61 34.58%
PAT 8.14 54.24 -84.99% 45.24 51.16 -11.57% 86.60 14.61 492.74% 34.02 22.49 51.27%
PATM 4.25% 22.90% 16.22% 17.65% 38.86% 9.07% 15.47% 11.27%
EPS 0.94 6.75 -86.07% 5.57 6.23 -10.59% 10.59 1.93 448.70% 4.24 2.93 44.71%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 848.55 805.97 663.88 741.29 733.67 675.79 565.40 527.37 328.20 279.76 257.54 Net Sales Growth 8.92% 21.40% -10.44% 1.04% 8.56% 19.52% 7.21% 60.69% 17.31% 8.63% Cost Of Goods Sold 287.08 258.38 229.62 348.45 365.75 359.49 309.52 305.03 205.00 174.56 153.87 Gross Profit 561.47 547.60 434.26 392.85 367.92 316.30 255.88 222.34 123.19 105.20 103.67 GP Margin 66.17% 67.94% 65.41% 53.00% 50.15% 46.80% 45.26% 42.16% 37.54% 37.60% 40.25% Total Expenditure 609.62 568.18 494.86 573.43 560.97 511.35 431.01 409.65 262.79 223.47 188.15 Power & Fuel Cost - 35.31 31.39 27.00 24.56 20.54 17.58 15.55 8.83 7.63 5.65 % Of Sales - 4.38% 4.73% 3.64% 3.35% 3.04% 3.11% 2.95% 2.69% 2.73% 2.19% Employee Cost - 149.28 124.66 113.29 91.53 67.27 56.49 42.13 22.76 16.94 12.85 % Of Sales - 18.52% 18.78% 15.28% 12.48% 9.95% 9.99% 7.99% 6.93% 6.06% 4.99% Manufacturing Exp. - 75.34 55.63 55.48 50.58 42.10 29.78 22.80 13.28 10.20 7.83 % Of Sales - 9.35% 8.38% 7.48% 6.89% 6.23% 5.27% 4.32% 4.05% 3.65% 3.04% General & Admin Exp. - 24.76 16.55 12.15 11.52 9.00 6.57 6.41 7.67 6.45 4.02 % Of Sales - 3.07% 2.49% 1.64% 1.57% 1.33% 1.16% 1.22% 2.34% 2.31% 1.56% Selling & Distn. Exp. - 10.04 6.51 6.00 4.51 7.24 5.83 7.22 4.11 3.03 2.84 % Of Sales - 1.25% 0.98% 0.81% 0.61% 1.07% 1.03% 1.37% 1.25% 1.08% 1.10% Miscellaneous Exp. - 15.07 30.50 11.06 12.52 5.71 5.25 10.51 1.12 4.67 2.84 % Of Sales - 1.87% 4.59% 1.49% 1.71% 0.84% 0.93% 1.99% 0.34% 1.67% 0.42% EBITDA 238.94 237.79 169.02 167.86 172.70 164.44 134.39 117.72 65.41 56.29 69.39 EBITDA Margin 28.16% 29.50% 25.46% 22.64% 23.54% 24.33% 23.77% 22.32% 19.93% 20.12% 26.94% Other Income 21.74 40.02 17.16 34.52 29.82 11.14 7.51 8.85 5.01 7.79 9.10 Interest 12.12 4.33 2.79 2.12 2.79 3.27 3.88 3.40 1.95 1.97 2.27 Depreciation 39.39 34.96 34.01 32.78 26.66 21.19 19.09 21.09 12.75 11.44 10.42 PBT 257.57 238.53 149.38 167.49 173.08 151.12 118.93 102.08 55.72 50.66 65.79 Tax 74.41 40.27 31.49 34.25 41.09 35.84 34.84 21.23 9.65 11.54 14.91 Tax Rate 28.89% 17.21% 20.24% 20.45% 24.38% 24.10% 29.29% 20.80% 17.35% 22.50% 22.66% PAT 183.16 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 50.88 PAT before Minority Interest 183.16 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 50.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.59% 24.04% 18.69% 17.97% 17.37% 16.70% 14.87% 15.33% 14.00% 14.21% 19.76% PAT Growth 13.27% 56.09% -6.85% 4.54% 12.93% 34.20% 4.01% 75.94% 15.62% -21.88% EPS 22.47 23.77 15.23 16.35 15.64 13.85 10.32 9.92 5.64 4.88 6.24

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 913.05 907.91 733.39 788.83 779.16 716.43 613.80 571.38 371.32 318.18 290.29 Net Sales Growth 2.90% 23.80% -7.03% 1.24% 8.76% 16.72% 7.42% 53.88% 16.70% 9.61% Cost Of Goods Sold 300.94 277.73 257.03 355.87 371.81 366.19 323.16 313.26 213.95 183.22 162.98 Gross Profit 612.11 630.18 476.36 432.95 407.36 350.25 290.63 258.12 157.38 134.96 127.31 GP Margin 67.04% 69.41% 64.95% 54.89% 52.28% 48.89% 47.35% 45.17% 42.38% 42.42% 43.86% Total Expenditure 712.04 693.39 579.39 637.60 617.55 556.44 487.38 455.40 301.63 257.08 219.70 Power & Fuel Cost - 38.76 33.57 28.86 26.30 21.90 19.29 17.37 10.67 9.38 7.03 % Of Sales - 4.27% 4.58% 3.66% 3.38% 3.06% 3.14% 3.04% 2.87% 2.95% 2.42% Employee Cost - 196.59 176.40 149.35 127.87 90.09 82.30 67.83 42.56 33.68 28.37 % Of Sales - 21.65% 24.05% 18.93% 16.41% 12.57% 13.41% 11.87% 11.46% 10.59% 9.77% Manufacturing Exp. - 79.19 61.23 59.96 52.55 45.35 36.55 27.44 16.92 12.89 8.35 % Of Sales - 8.72% 8.35% 7.60% 6.74% 6.33% 5.95% 4.80% 4.56% 4.05% 2.88% General & Admin Exp. - 70.26 27.20 22.50 16.95 14.11 10.64 9.53 9.51 7.87 5.64 % Of Sales - 7.74% 3.71% 2.85% 2.18% 1.97% 1.73% 1.67% 2.56% 2.47% 1.94% Selling & Distn. Exp. - 10.40 6.72 6.37 4.75 7.27 5.99 7.29 4.43 3.19 4.63 % Of Sales - 1.15% 0.92% 0.81% 0.61% 1.01% 0.98% 1.28% 1.19% 1.00% 1.59% Miscellaneous Exp. - 20.47 17.23 14.68 17.32 11.54 9.45 12.68 3.59 6.86 4.63 % Of Sales - 2.25% 2.35% 1.86% 2.22% 1.61% 1.54% 2.22% 0.97% 2.16% 0.93% EBITDA 201.00 214.52 154.00 151.23 161.61 159.99 126.42 115.98 69.69 61.10 70.59 EBITDA Margin 22.01% 23.63% 21.00% 19.17% 20.74% 22.33% 20.60% 20.30% 18.77% 19.20% 24.32% Other Income 32.20 22.22 15.56 32.62 29.34 11.36 6.93 9.12 5.01 8.28 8.95 Interest 13.76 4.56 3.68 2.66 3.13 3.93 4.05 3.52 2.27 2.31 2.63 Depreciation 50.30 43.78 42.06 37.22 30.64 23.14 21.41 23.22 15.34 14.36 12.96 PBT 229.59 188.40 123.82 143.96 157.17 144.28 107.89 98.35 57.10 52.71 63.95 Tax 55.60 33.49 26.18 33.91 42.04 35.62 35.22 20.30 9.53 12.22 14.60 Tax Rate 24.22% 17.78% 18.22% 23.56% 27.54% 25.11% 32.66% 21.27% 16.72% 22.91% 22.83% PAT 174.00 156.50 120.28 112.43 113.71 109.84 73.69 75.67 47.35 41.23 49.35 PAT before Minority Interest 175.05 154.91 117.52 110.05 110.59 106.24 72.62 75.15 47.47 41.11 49.35 Minority Interest 1.05 1.59 2.76 2.38 3.12 3.60 1.07 0.52 -0.12 0.12 0.00 PAT Margin 19.06% 17.24% 16.40% 14.25% 14.59% 15.33% 12.01% 13.24% 12.75% 12.96% 17.00% PAT Growth 22.11% 30.11% 6.98% -1.13% 3.52% 49.06% -2.62% 59.81% 14.84% -16.45% EPS 21.35 19.20 14.76 13.80 13.95 13.48 9.04 9.28 5.81 5.06 6.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,453.42 1,281.55 1,156.98 1,029.62 664.59 563.10 412.56 330.79 287.30 235.21 Share Capital 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 4.80 Total Reserves 1,445.27 1,273.39 1,148.83 1,021.60 656.88 555.39 405.21 325.88 282.39 226.03 Non-Current Liabilities 208.00 157.15 139.08 241.14 59.29 59.43 65.23 64.16 24.94 27.02 Secured Loans 164.48 80.39 67.08 141.18 0.00 16.23 37.38 43.22 5.07 11.16 Unsecured Loans 0.00 0.70 1.03 1.30 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 8.72 5.36 5.08 5.55 4.32 3.89 0.88 0.31 0.76 0.60 Current Liabilities 359.86 229.59 251.05 219.71 205.32 160.13 149.05 111.97 109.74 68.37 Trade Payables 76.63 71.37 98.86 103.91 98.20 65.58 86.61 47.74 53.13 24.00 Other Current Liabilities 119.85 76.53 56.68 25.20 25.74 38.28 35.64 21.51 18.28 14.27 Short Term Borrowings 156.40 78.72 92.95 88.04 69.59 50.84 22.02 38.92 35.73 27.86 Short Term Provisions 6.97 2.97 2.57 2.55 11.79 5.43 4.78 3.80 2.60 2.24 Total Liabilities 2,021.28 1,668.29 1,547.11 1,490.47 929.20 782.66 626.84 506.92 421.98 330.60 Net Block 517.00 510.84 488.69 448.85 349.77 280.01 257.66 152.56 140.84 127.09 Gross Block 756.00 723.32 666.58 594.31 469.21 378.74 338.75 212.70 188.18 163.00 Accumulated Depreciation 238.99 212.49 177.89 145.46 119.44 98.73 81.09 60.14 47.34 35.90 Non Current Assets 1,113.59 1,147.87 893.90 786.14 597.17 497.66 402.49 324.23 246.74 159.19 Capital Work in Progress 372.81 401.21 200.99 136.51 89.38 87.71 49.24 114.27 55.27 1.25 Non Current Investment 93.48 89.04 111.35 101.78 94.05 74.24 65.07 37.01 33.11 28.08 Long Term Loans & Adv. 124.54 119.95 68.04 94.26 58.65 55.60 30.48 19.99 17.18 2.46 Other Non Current Assets 5.76 26.83 24.83 4.75 5.31 0.08 0.05 0.40 0.34 0.30 Current Assets 907.69 520.42 653.22 704.32 332.03 284.99 224.36 182.69 175.24 171.41 Current Investments 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 0.00 Inventories 206.23 176.70 167.72 174.96 124.66 120.88 108.95 66.13 59.87 37.44 Sundry Debtors 226.54 181.68 218.14 166.50 111.98 70.12 60.31 31.88 33.19 33.63 Cash & Bank 28.19 90.93 73.14 93.10 5.66 2.49 0.81 10.53 1.95 83.75 Other Current Assets 446.73 55.40 28.59 23.24 30.11 26.15 44.15 23.87 12.22 16.59 Short Term Loans & Adv. 30.17 15.70 46.09 21.91 15.56 4.95 26.77 12.66 5.71 10.51 Net Current Assets 547.83 290.83 402.16 484.62 126.71 124.87 75.31 70.72 65.50 103.04 Total Assets 2,021.28 1,668.29 1,547.12 1,490.46 929.20 782.65 626.85 506.92 421.98 330.60

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,329.36 1,197.58 1,085.03 986.90 639.26 546.94 396.45 320.42 275.98 224.68 Share Capital 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 4.80 Total Reserves 1,321.21 1,189.43 1,076.88 978.88 631.55 539.23 389.09 315.52 271.07 213.85 Non-Current Liabilities 256.94 166.62 153.48 251.26 67.23 154.15 104.53 98.51 31.13 31.85 Secured Loans 164.48 80.39 67.09 141.20 0.03 71.03 37.43 70.47 5.07 11.42 Unsecured Loans 0.53 0.70 1.03 1.30 0.00 31.30 30.05 0.00 0.00 0.00 Long Term Provisions 26.17 21.77 20.32 16.89 13.96 11.75 9.93 6.92 6.34 5.71 Current Liabilities 407.74 253.44 265.84 236.90 222.07 189.06 166.84 123.77 121.14 80.21 Trade Payables 89.46 80.72 103.74 111.86 106.48 75.50 92.98 51.26 56.72 27.90 Other Current Liabilities 142.11 81.62 59.59 28.03 36.49 49.32 38.23 23.38 20.34 16.65 Short Term Borrowings 165.27 86.58 98.12 92.41 74.10 58.47 30.27 45.07 41.24 33.15 Short Term Provisions 10.90 4.52 4.39 4.60 5.00 5.77 5.37 4.06 2.83 2.51 Total Liabilities 1,986.13 1,610.02 1,499.13 1,472.22 930.89 904.54 677.83 551.42 433.11 338.21 Net Block 650.44 558.01 534.20 491.93 393.41 316.06 294.42 180.67 166.61 146.25 Gross Block 986.42 853.16 793.24 704.89 582.20 476.34 448.38 300.89 271.30 232.84 Accumulated Depreciation 335.98 295.15 259.04 212.96 188.79 160.28 153.96 120.22 104.70 86.59 Non Current Assets 1,365.35 1,064.96 827.16 742.33 576.68 576.77 443.89 339.18 244.95 159.79 Capital Work in Progress 666.25 429.12 209.85 140.51 91.90 221.62 111.03 129.15 57.71 2.72 Non Current Investment 10.45 2.25 20.79 27.99 34.15 0.19 0.21 0.14 0.11 3.65 Long Term Loans & Adv. 32.42 48.75 37.47 77.09 51.86 38.74 38.18 28.82 20.17 6.62 Other Non Current Assets 5.78 26.84 24.86 4.80 5.36 0.16 0.06 0.40 0.34 0.00 Current Assets 620.78 545.06 671.97 729.88 354.21 327.61 233.74 211.99 187.87 178.39 Current Investments 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 0.00 Inventories 226.43 187.67 188.71 190.00 134.23 130.78 123.25 74.33 67.32 43.33 Sundry Debtors 243.72 203.73 220.27 170.93 125.43 81.37 67.96 41.79 40.53 40.13 Cash & Bank 44.56 94.54 73.83 100.39 11.03 18.42 9.19 16.87 2.27 87.20 Other Current Assets 106.06 45.04 26.08 22.00 23.90 31.69 23.20 28.72 9.72 7.72 Short Term Loans & Adv. 29.25 14.08 43.54 21.95 8.90 4.91 3.23 2.86 3.01 1.56 Net Current Assets 213.04 291.62 406.13 492.98 132.14 138.55 66.90 88.22 66.73 98.18 Total Assets 1,986.13 1,610.02 1,499.13 1,472.21 930.89 904.54 677.83 551.42 433.10 338.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 129.79 164.16 54.46 50.49 119.65 67.35 58.99 35.95 49.57 32.44 PBT 233.99 155.60 167.49 168.53 148.70 118.93 102.08 55.61 51.29 65.84 Adjustment -5.39 25.78 8.68 15.28 18.05 22.61 16.42 8.34 7.28 6.66 Changes in Working Capital -57.95 18.23 -81.25 -99.93 -15.54 -49.19 -38.22 -17.11 -1.22 -27.41 Cash after chg. in Working capital 170.65 199.61 94.92 83.89 151.21 92.35 80.29 46.84 57.35 45.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -40.85 -35.45 -40.45 -33.40 -31.55 -25.01 -21.30 -10.89 -7.78 -12.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -295.08 -214.71 -12.83 -274.78 -100.98 -139.48 -38.20 -63.04 -144.57 -9.02 Net Fixed Assets -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 -5.23 Net Investments -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 -24.39 Others -286.36 -99.60 28.41 70.17 5.25 3.36 10.74 6.64 7.68 20.60 Cash from Financing Activity 170.10 8.17 -61.16 315.27 -14.58 73.82 -30.51 35.67 12.99 58.24 Net Cash Inflow / Outflow 4.82 -42.38 -19.53 90.98 4.09 1.69 -9.72 8.58 -82.01 81.66 Opening Cash & Equivalents 30.76 73.14 92.68 1.70 -3.02 0.81 10.53 1.95 83.96 2.09 Closing Cash & Equivalent 28.19 30.76 73.14 92.68 1.07 2.49 0.81 10.53 1.95 83.75

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 123.72 146.78 44.92 37.48 128.70 68.81 70.04 43.64 56.73 40.86 PBT 188.40 143.70 136.77 146.49 140.36 107.84 95.45 57.00 53.51 64.13 Adjustment 41.32 20.44 18.83 17.19 20.61 26.46 19.62 11.52 10.19 10.42 Changes in Working Capital -63.80 18.71 -69.66 -92.61 -2.70 -40.11 -23.44 -13.90 0.77 -21.04 Cash after chg. in Working capital 165.92 182.85 85.94 71.08 158.27 94.19 91.62 54.62 64.46 53.51 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -42.20 -36.07 -41.02 -33.60 -29.56 -25.38 -21.58 -10.98 -7.73 -12.61 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -288.85 -196.16 -8.76 -262.23 -109.20 -195.18 -48.93 -95.21 -152.31 7.77 Net Fixed Assets -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 -5.23 Net Investments -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 -24.39 Others -280.13 -81.05 32.48 82.72 -2.97 -52.34 0.01 -25.53 -0.06 37.39 Cash from Financing Activity 175.50 10.06 -60.91 312.70 -19.65 135.05 -28.34 66.31 10.02 35.93 Net Cash Inflow / Outflow 10.38 -39.32 -24.75 87.95 -0.15 8.68 -7.23 14.74 -85.56 84.56 Opening Cash & Equivalents 34.36 73.83 99.97 7.05 3.61 9.19 16.87 2.27 87.83 2.65 Closing Cash & Equivalent 44.56 34.36 73.83 99.97 6.43 18.42 9.19 16.87 2.27 87.20

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 178.28 157.19 141.91 128.50 86.20 73.03 112.15 89.92 78.10 64.06 ROA 10.50% 7.72% 8.77% 10.53% 13.19% 11.93% 14.26% 9.90% 10.56% 17.77% ROE 14.17% 10.18% 12.19% 15.05% 18.39% 17.24% 21.75% 14.87% 15.34% 29.67% ROCE 14.44% 11.27% 13.00% 16.98% 21.70% 21.49% 22.89% 14.93% 16.97% 29.19% Fixed Asset Turnover 1.09 0.96 1.18 1.39 1.61 1.59 1.94 1.67 1.62 1.65 Receivable days 92.44 109.91 94.36 68.87 48.77 41.69 31.48 35.42 42.78 45.13 Inventory Days 86.71 94.68 84.06 74.10 65.76 73.47 59.79 68.58 62.31 56.19 Payable days 46.77 62.82 63.90 61.73 57.90 62.98 59.11 68.15 62.12 57.27 Cash Conversion Cycle 132.38 141.78 114.52 81.24 56.63 52.19 32.17 35.85 42.98 44.05 Total Debt/Equity 0.26 0.15 0.16 0.23 0.13 0.15 0.19 0.30 0.19 0.22 Interest Cover 55.05 56.69 79.92 61.31 46.45 31.65 31.05 29.59 27.03 29.94

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 163.06 146.89 133.09 123.17 82.91 70.92 107.72 43.52 74.94 60.67 ROA 8.62% 7.56% 7.41% 9.20% 11.58% 9.18% 12.23% 9.64% 10.66% 16.84% ROE 12.26% 10.30% 10.62% 13.60% 17.92% 15.40% 20.98% 15.93% 16.63% 30.96% ROCE 12.41% 11.05% 11.71% 15.91% 19.90% 17.90% 20.48% 15.04% 18.02% 28.98% Fixed Asset Turnover 0.99 0.89 1.06 1.22 1.36 1.34 1.54 1.32 1.28 1.30 Receivable days 89.94 105.51 90.20 69.00 52.26 43.99 34.62 39.70 45.47 46.24 Inventory Days 83.24 93.66 87.32 75.49 66.97 74.84 62.33 68.31 62.38 57.79 Payable days 46.83 58.00 61.51 60.89 60.10 62.86 57.06 63.94 59.10 55.44 Cash Conversion Cycle 126.35 141.17 116.00 83.61 59.13 55.97 39.90 44.07 48.76 48.59 Total Debt/Equity 0.29 0.16 0.18 0.24 0.14 0.34 0.30 0.41 0.22 0.26 Interest Cover 42.34 40.09 55.10 49.69 37.07 27.63 28.09 26.13 24.13 25.28

Top Investors:

tano mauritius india fvci ii

ta fii investors limited

pivotal enterprises private limited

icici prudential bharat consumption fund - series 2

pivotal business managers llp

amal n parikh

duro one investments limited

nippon life india trustee ltd-a/c nippon india nifty small cap 250 index fund

qualified institutional buyer

iepf

Annual Reports:

News Update:

Shilpa Medicare gets tentative USFDA’s nod for Apremilast tablets
5th Mar 2021, 13:40 PM

The newly approved product is a generic equivalent of reference listed drug (RLD) Otezla of Celgene
Read More
Shilpa Medicare launches first women intimate cleansing spray ‘SwatchShil’
4th Mar 2021, 11:56 AM

‘SwatchShil’ will give Shilpa an entry with differentiated products into rapidly growing Women intimate hygiene products segment
Read More
Shilpa Medicare receives import alert
18th Feb 2021, 12:51 PM

Three products have been exempted from the Import Alert - Azacitidine for Injection, Cyclophosphamide Capsules and Erlotinib Tablets
Read More
Shilpa Medicare launches Sunitinib Capsules
15th Feb 2021, 12:17 PM

Three strengths of Sunitinib capsules 12. 5 mg, 25 mg and 50 mg is launched at an attractive price for the benefit of patients
Read More

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: